Published in

Springer Verlag, PharmacoEconomics, 10(37), p. 1195-1207, 2019

DOI: 10.1007/s40273-019-00792-7

Links

Tools

Export citation

Search in Google Scholar

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO